317
Participants
Start Date
March 31, 2014
Primary Completion Date
January 8, 2018
Study Completion Date
January 8, 2018
Selinexor
Selinexor oral tablet.
Hydroxyurea
Ara-C
Ara-C Subcutaneous Injection.
Memorial Sloan Kettering Cancer Center, New York
New York Presbyterian Hospital / Weill Cornell Medical College, New York
Westchester Medical Center / New York Medical College, Hawthorne
Stellvertretende Klinikleiterin Charité, Campus Benjamin Franklin, Berlin
Roswell Park Cancer Institute, Buffalo
Milton S. Hershey Medical Center / Penn State, Hershey
Sidney Kimmel Comprehensive Cancer Center / John Hopkins University, Baltimore
Duke Cancer Care, Durham
Winship Cancer Institute / Emory University, Atlanta
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Tennessee Oncology/Sarah Cannon Research Institute, Nashville
Vanderbilt-Ingram Cancer Center / Vanderbilt University, Nashville
Ohio State University Comprehensive Cancer Center, Columbus
Gabrail Cancer Center, Canton
Chaim Sheba Medical Center, Tel Litwinsky
Northwestern University, Chicago
University of Chicago Medicine, Chicago
University of Kansas Hospital, Kansas City
MD Anderson Cancer Center / University of Texas, Houston
Texas Transplant Institute/Sarah Cannon Research Institute, San Antonio
Colorado Blood Cancer Institute/Sarah Cannon Research Institute, Denver
Sororka MC, Beersheba
Jonsson Comprehensive Cancer Center / University of California, Los Angeles, Los Angeles
Hadassah Medical Center, Jerusalem
Stanford Cancer Institute / Stanford University, Stanford
Sutter Oncology & Hematology, Sacramento
Rambam Health Care Campus, Haifa
Rabin Medical Center, Petah Tikva
Yale Cancer Center / Yale University, New Haven
University of Massachusetts Medical School, Worcester
University of Michigan Comprehensive Cancer Center, Ann Arbor
Hackensack University Medical Center, Hackensack
Tom Baker Cancer Centre, Calgary
University of Alberta, Edmonton
Sir Mortimer B. Davis Jewish General Hospital / McGill University, Montreal
Aarhus University Hospital, Aarhus
Department of Haematology, National University Hospital, Rigshospitalet, Copenhagen
Herlev Hospital, Herlev
Odense University Hospital, Department of Hematology, Odense
CHU Bordeaux- Hôpital Haut Lévêque, Bordeaux
Centre Hospitalier Lyon, Lyon
Hopital Saint Louis, Paris
Hôpital Avicenne, Paris
Institut Universitaire du Cancer Toulouse, Toulouse
Ev. Diakonie-Krankenhaus Gemeinnutzige GMBH Medizinische Klinik 2, Bremen
UNIVERSITÄTSKLINIKUM TU DRESDEN Medizinische Klinik und Poliklinik I,, Dresden
University Hospital Frankfurt, Frankfurt
Medizinische Hochschule Hannover (Hannover Medical School) Dept. of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hanover
Abteilung Hämatologie, internistische Onkologie und Hämostaseologie, Leipzig
UNIVERSITY HOSPITAL OF MÜNSTER Medizinische Klinik und Poliklinik A, Universitätsklinikum Münster, Münster
Universitätsklinikum Ulm, Ulm
Wolfson Medical Center, Holon
Tel Aviv Sourasky Medical Centre, Tel Aviv
AOU Ospedali Riuniti di Ancona, Ancona
A.O Spedali Civili di Brescia, Brescia
AORN Cardarelli / UOSC di Ematologia con TMO, Naples
AMC, Academisch Medisch Centrum Afdeling Klinische Hematologie, Amsterdam
VU University Medical Center, Amsterdam
Universitair Medisch Centrum Groningen Department of Haematology, Groningen
Radboud University Medical Center Department of Haematology (476), Nijmegen
Erasmus MC, location Daniel den Hoed, Rotterdam
University Medical Center Utrecht, Utrecht
Isala Kliniecken Zwolle, Zwolle
Wojewódzki Szpital Specjalistyczny im. M. Kopernika, Klinika Hematologii, Lodz
Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych, Olsztyn
Instytut Hematologii i Transfuzjologii, Warsaw
Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocławiu, Wroclaw
Hospital del Mar, Barcelona
Hospital Universitario de Salamanca Servicio de Hematologia, Salamanca
Hospital Universitario y Politécnico La Fe, Valencia
Plymouth Hospitals NHS Trust/Derriford Hospital, Plymouth
ICO Badalona, Badalona
Northwick Park Hospital, Harrow
Royal Liverpool University Hospital, Dept of Cellular and Molecular Physiology, Molecular and Clinical Cancer Medicine, Liverpool
Royal Marsden NHS Trust, Sutton
University Hospital Wales, Cardiff
Hull and East Yorkshire Hospitals NHS Trust Queens Centre for Oncology and Haematology, Hull
Ninewells Hospital and Medical School NHS Tayside, Dundee
Lead Sponsor
Karyopharm Therapeutics Inc
INDUSTRY